Although there is currently no cure for macular degeneration a recent study sponsored by the National Eye Institute is gaining attention for macular degeneration treatment. According to the Age Related Eye Disease Study, or AREDS, there are macular degeneration vitamins you can take to slow your vision loss associated with age related vision loss problems, this includes dry macular degeneration.

The study found that taking a certain combination of vitamin and minerals slowed the progression of vision loss from macular degeneration as well as aids in halting its progression to the advanced stage of the disease.

The combination includes the following components:

5 Macular Degeneration Vitamins and Minerals

• 500 mg vitamin C
• 400 IU vitamin E
• 15 mg beta carotene
• 80 mg zinc
• 2 mg copper

This powerful combination of vitamins and minerals is loaded with antioxidants. Taken on a regular, consistent basis this macular degeneration vitamin combo has been shown to slow vision loss and progression of the disease into the later stages.

And according to experts at the National Eye Institute this potent vitamin formula has been found to be effective only for those with macular degeneration (wet or dry) in the intermediate (dry) or advanced (wet or dry) stages.

Macular Degeneration Diet

The AREDS recommended supplement plan for macular degeneration sufferers in the advanced stages of the disease is hard to obtain by diet alone. With it’s high levels of certain vitamins and minerals it would be a challenge to eat that amount of each nutrient in your daily diet.

However, there are certain foods you can eat that have been proven to be beneficial for the eyes.

A diet rich in green, leafy vegetables that are high in vitamins A, C, and E have been associated with a lower risk of developing macular degeneration. There is currently no evidence to suggest that this type of diet can reverse or slow the progression of macular degeneration.

It’s important to note that a new study being sponsored by the National Eye Institute is focusing on the potential benefits of a diet high in lutein, zeaxantin, and omega-3 fatty acids to lower the risk of developing macular degeneration.

How to Decrease Your Risk of Developing Macular Degeneration

Eating a healthy diet isn’t just important for protecting your eye health and preventing macular degeneration, it’s vital for a healthy body. The benefits to eating a whole foods, fresh foods diet that avoids processed and refined foods are immeasurable.

In addition to paying attention to what you eat there are lifestyle choices you can make to lower your chance of developing macular degeneration as well as many other debilitating diseases.

Avoid smoking, excessive stress, obesity, and other unhealthy lifestyle habits. Make it a point to be regularly checked out by your doctors including the eye doctor and dentist.

Living an all around healthy life will help you to decrease your risk of developing macular degeneration.

Alternative Treatments for Macular Degeneration

There are a number of people who have turned to alternative, herbal therapies for treatment of macular degeneration. Although there is no evidence that any of these work the following are used most often to treat macular degeneration with some users claiming success:

• Bilberry
• Ginkgo
• Shark cartilage

These may interfere with other medicines you may be taking so it’s vital to check with your health care practitioner before beginning any alternative treatment program.

There are advances on a daily basis with many diseases. If you suffer with macular degeneration stay up on current studies and research, eat healthy, and take the steps necessary to maintain the highest quality of life.

Reference:

http://www.nei.nih.gov/health/maculardegen/armd_facts.asp

FOR IMMEDIATE RELEASE
October 15, 2009

(Minneapolis, MN) The Eniva green tea complex found within the VIBE nutraceutical product has been chosen as the key component of one of the largest breast cancer risk reduction studies ever to be performed. This National Institute of Health (NIH) funded study entitled “Green Tea and Reduction of Breast Cancer Risk” is currently being undertaken by researchers at the University of Minnesota and will look to explore the relationship between green tea and green tea components, such as catechins and epigallocatechin gallate (EGCG), and the potential reduction in risk of developing breast cancer.

Breast cancer is currently the leading type of cancer in women and rates are rapidly rising. Specifically, the risk of occurrence is increasing in Asian American women, a group historically with the lowest risk for developing breast cancer. Breast cancer is one of the leading killers in women and although much is known about lifestyle factors that influence a woman’s risk of breast cancer, few are readily adaptable to cancer prevention practices or strategies. To date, no effective chemopreventive agent against breast cancer in humans has been identified.

The “Green Tea and Reduction of Breast Cancer Risk” study is a phase II, randomized, double-blind, placebo-controlled, multi-year study that will follow 800 female participants. The study objective is to develop correlations between breast cancer risk factors and the therapeutic use of derivatives from green tea through a specialized and proprietary green tea catechin complex. The study targets several factors to determine breast cancer risk, while exploring methods to reduce that risk of developing breast cancer. Specific factors the study will evaluate are mammographic density of the breast, circulating concentrations of insulin-like growth factors (IGF1 and IGFBP3) and F-2 isoprostanes, identifying the levels of biomarkers such as reproductive hormones (estrone, estradiol, androstenedione) and sex hormone binding globulin, urinary hormone biomarkers, and evaluations of genetic profiles. This will be the first study to examine the effects of specific derivatives of green tea on these multiple bio-factors.

After several scientific meetings and discussions, the green tea catechin complex to be tested was selected by study researchers due to previous data and meeting identified specific criteria. The green tea complex selected for the “Green Tea and Reduction of Breast Cancer Risk” study is of identical nature to the proprietary green tea complex used in the Eniva VIBE Nutraceutical. While the concentration used in the current study is of a much higher value, its base complex is identical. Stated Chief Medical Officer of Eniva Nutraceutics, Dr. Benjamin Baechler, “We are excited to have played a role in further defining strategies to help address one of the leading causes of morbidity and mortality in women.” Eniva Nutraceutics is a manufacturer and global marketer of high quality, science-based dietary supplements known as nutraceuticals. It carries a product line of over 75 wellness products, ranging from cardiovascular to general health and wellness. The corporation recently celebrated its eleventh-year annivsary at its new state-of-the art research and development facility and world headquarters in Anoka, Minnesota.

Published by Eniva Corporation

In its pursuit to establish VIBE as the leading liquid nutraceutical in the marketplace, Eniva Corporation’s VIBE Original has recently received significant industry recognition for ensuring quality product stnadards from Consumer Labs. Consumer Labs has long been recognized as the “gold-testing standard” for consistency, purity, and quality amongst nutritional products. Consumer Lab’s stringent testing of Eniva’s VIBE Original product has resulted in CL’s issuance of quality approval for the VIBE Original product.

As an independent certification company, Consumer Labs provides testing for a large number of dietary and healtcare manufacturers. Products are tested and clinically certified for marketing to the general public. In a competitive consumer environment, the CL approval label is an added mark of assurance for individuals consuming a dietary or health product.

The CL “Approved Quality” logo will soon be appearing on VIBE Original bottles. Eniva CEO, Andrew Baechler, responded to the approval, “There are a limited number of products in the NWM that carry this approval on their label, and even fewer liquid producuts that can consistently meet CL’s strict standards. We are very pleased VIBE Original is one of the very first liquid products to carry this industry recognized seal of quality.”

For more information, go to http://www.enivaquality.com/

This article taken from “Vibe Today” Volume 1 published by Eniva Corporation.

Excerpt from Vibe Today Newsletter Volume 3 published by Eniva Corporation

Minneapolis, MN(Eniva Quality News) – The Eniva Research Group has released results from laboratory testing by the world-famous Linus Pauling Micronutrient Research Institute at Oregon State University which demonstrated the Eniva Health Supplement VIBE® possessed DNA protective anti-mutagenic activity for human cells. This third party testing was performed as part of an ongoing investigative effort to further identify mechanisms by which the Eniva VIBE nutraceutical impacts human health.

Chief Scientific Officer for Eniva Corporation, Dr. Benjamin Baechler, stated, “While these results are tremendously exciting and give us insight into one of the mechanisms of action of the VIBE nutraceutical, we must be careful not to generalize these results beyond the study findings. What we can say for certain is these results further demonstrate the ability of the VIBE nutraceutical to help support healthy and normal functioning of human cells, even under very stressful physiologic situations.”

The research design consisted of culturing human cells with and without the VIBE nutraceutical and then exposing these human cells to a well known DNA mutagen–ultraviolet radiation. After a period of time, the human skin cells were then obtained and examined for specific damage to their DNA. Results were compared between the human cells supported by VIBE in their growth medium and those without it. The results demonstrated an extremely statistically significant decrease in DNA damage in those human cells which were supported with the VIBE nutraceutical (p-value http://www.enivanutraceutics.com/.